HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Physiol. Rev. 87: 521-544, 2007; doi:10.1152/physrev.00032.2006
0031-9333/07 $18.00

This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Ahuja, P. Articles by MacLellan, W. R. Search for Related Content PubMed PubMed Citation Articles by Ahuja, P. Articles by MacLellan, W. R.

Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration

Division of Cardiology, University of California at Los Angeles, and The Cardiovascular Research Laboratories, Department of Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California

Cardiac myocytes rapidly proliferate during fetal life but exit the cell cycle soon after birth in mammals. Although the extent to which adult cardiac myocytes are capable of cell cycle reentry is controversial and species-specific differences may exist, it appears that for the vast majority of adult cardiac myocytes the predominant form of growth postnatally is an increase in cell size (hypertrophy) not number. Unfortunately, this limits the ability of the heart to restore function after any significant injury. Interest in novel regenerative therapies has led to the accumulation of much information on the mechanisms that regulate the rapid proliferation of cardiac myocytes in utero, their cell cycle exit in the perinatal period, and the permanent arrest (terminal differentiation) in adult myocytes. The recent identification of cardiac progenitor cells capable of giving rise to cardiac myocyte-like cells has challenged the dogma that the heart is a terminally differentiated organ and opened new prospects for cardiac regeneration. In this review, we summarize the current understanding of cardiomyocyte cell cycle control in normal development and disease. In addition, we also discuss the potential usefulness of cardiomyocyte self-renewal as well as feasibility of therapeutic manipulation of the cardiac myocyte cell cycle for cardiac regeneration.

This article has been cited by other articles:

				C. M. Trivedi, M. M. Lu, Q. Wang, and J. A. Epstein Transgenic Overexpression of Hdac3 in the Heart Produces Increased Postnatal Cardiac Myocyte Proliferation but Does Not Induce Hypertrophy J. Biol. Chem., September 26, 2008; 283(39): 26484 - 26489. [Abstract] [Full Text] [PDF]

				H. J. Evans-Anderson, C. M. Alfieri, and K. E. Yutzey Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors Circ. Res., March 28, 2008; 102(6): 686 - 694. [Abstract] [Full Text] [PDF]

				S. Meiners, H. Dreger, M. Fechner, S. Bieler, W. Rother, C. Gunther, G. Baumann, V. Stangl, and K. Stangl Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System Hypertension, February 1, 2008; 51(2): 302 - 308. [Abstract] [Full Text] [PDF]

				I. Banerjee, J. W. Fuseler, R. L. Price, T. K. Borg, and T. A. Baudino Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1883 - H1891. [Abstract] [Full Text] [PDF]

				R. Kitamura, T. Takahashi, N. Nakajima, K. Isodono, S. Asada, H. Ueno, T. Ueyama, T. Yoshikawa, H. Matsubara, and H. Oh Stage-Specific Role of Endogenous Smad2 Activation in Cardiomyogenesis of Embryonic Stem Cells Circ. Res., July 6, 2007; 101(1): 78 - 87. [Abstract] [Full Text] [PDF]